Digital PNG artwork · delivered by email | Secure checkout · no physical shipping

What is peripheral nerve regeneration?

Peripheral nerve regeneration is the biological process by which severed or damaged peripheral axons re-extend and re-innervate their targets, a process that remains incomplete after transection and drives research into

Peripheral nerve regeneration is the process by which axons of the peripheral nervous system re-extend after injury and attempt to re-establish functional contact with their target tissues. It is also referred to in the literature as peripheral nerve repair or peripheral nerve regeneration following peripheral nerve injury (PNI). The term describes a repair biology rather than a single molecular entity: no sequence, formula or molecular weight defines it, because it is a tissue-level outcome produced by the coordinated activity of Schwann cells, the axonal growth cone, the extracellular matrix and the inflammatory milieu. The evidence summarised here is drawn from preclinical models, principally rodent sciatic nerve preparations, and from in vitro hydrogel characterisation.

The experimental work on this page centres on growth factor signalling — specifically fibroblast growth factor-2 (FGF-2) delivered from a GelMA/Laponite nanocomposite — together with bone-derived nerve guidance conduits and a proposed synergistic pharmacological axis involving Hericium erinaceus, lithium and vitamin B12.

Research Studies

FGF-2 and the GelMA/Laponite nerve wrap interface

Peripheral nerve transection requires surgical treatment, and functional recovery after such surgery remains incomplete. A biofunctional nanocomposite nerve interface was developed that combines an ion-covalent gelatin methacryloyl (GelMA)/Laponite hydrogel with engineered thermostable FGF-2, with the aim of recreating a regenerative microenvironment [1]. Laponite incorporation at 2%–2.5% w/v modulated the hydrogel network, producing shear-thinning behaviour, enhanced viscoelasticity, microporosity, a twofold increase in compressive modulus, controlled degradation, injectability and three-dimensional (3D) bioprintability [1]. Functionalisation with thermostable FGF-2 enabled sustained release from the printed construct [1].

Laponite concentration and hydrogel network properties

The reported effects of Laponite loading on the GelMA network are summarised below. These are material characterisation values from the nanocomposite system, not physiological measurements.

ParameterReported effect of Laponite (2%–2.5% w/v)
Rheological behaviourShear-thinning
ViscoelasticityEnhanced
MicroporosityPresent
Compressive modulusTwofold increase
DegradationControlled
InjectabilityRetained
3D bioprintabilityRetained

Thermostable FGF-2 and sustained release

Engineering the growth factor for thermostability was the step that allowed FGF-2 to be carried in the printed hydrogel and released over time rather than losing activity during processing [1]. The design intent was a sustained rather than bolus exposure of the regenerating tissue to FGF-2 [1].

Bone-derived conduits and the 10 mm rat sciatic gap model

A separate line of work evaluated nerve guidance conduits (NGCs) fabricated from rat femoral diaphysis and chicken ulna as alternatives to conventional autologous and allogeneic grafts [2]. The rationale given is that peripheral nerve injuries pose a major clinical challenge when nerve gaps exceed 5 mm and spontaneous regeneration is inadequate [2]. Demineralised and decellularised bone scaffolds were characterised for collagen preservation, luminal geometry, and mechanical and electrical properties [2].

Rat femur versus chicken ulna conduit performance

In vivo, the conduits were implanted to bridge 10 mm sciatic nerve gaps in rats, with functional recovery assessed over 16 weeks [2]. The study was designed as a comparative in vivo evaluation of the two bone sources [2].

Conduit sourceModelGap bridgedAssessment period
Rat femoral diaphysisRat sciatic nerve10 mm16 weeks
Chicken ulnaRat sciatic nerve10 mm16 weeks

Decellularisation and decalcification of bone conduits

Both conduit types underwent demineralisation and decellularisation before implantation, and were characterised for collagen preservation, luminal geometry, and mechanical and electrical properties [2]. These processing steps are what convert bone tissue into a conduit intended to guide regenerating axons across a gap [2].

Hericium erinaceus, lithium and vitamin B12 in combination

A hypothesis paper reports that Hericium erinaceus, lithium and vitamin B12 have each individually demonstrated neuromodulatory activity, and proposes a triple neuromodulatory axis for peripheral nerve regeneration and synergistic pharmacology [3]. The paper frames peripheral nerve injury as frequently resulting in incomplete functional recovery, creating a translational gap despite advances in surgical technique [3]. This is a hypothesis, not a demonstrated in vivo combination result.

Where the evidence is animal-only or in vitro

The GelMA/Laponite/FGF-2 work is a materials and interface study: the hydrogel characterisation is in vitro, and the regenerative claims rest on the printed nerve wrap interface rather than on human data [1]. The bone conduit comparison is explicitly an in vivo study in rats, using rat and chicken donor tissue to bridge rat sciatic gaps [2]. The triple-axis proposal is a hypothesis paper [3]. No human efficacy data are presented in any of these sources.

If you are reading this for personal health reasons

The materials described on this page are supplied for laboratory research use only, and we do not provide dosing, clinical or medical guidance of any kind. Nothing here is a treatment recommendation, and none of the findings described have been established in humans. Anyone considering a compound for their own health should speak to a licensed clinician.

Sources

WhatsApp